Your institution may have access to this item. Find your institution then sign in to continue.
Title
Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab.
Authors
Ruyssen-Witrand, A; Rouanet, S; Combe, B; Dougados, M; Le Loët, X; Sibilia, J; Tebib, J; Mariette, X; Constantin, A
Abstract
To assess the association between a single nucleotide polymorphism in the gene of FCGR3A and the response to treatment with rituximab (RTX) in rheumatoid arthritis (RA).
Publication
Annals of the rheumatic diseases, 2012, Vol 71, Issue 6, p875